Abaloparatide vs Lanreotide
Overview
Abaloparatide is primarily a bone & joint peptide, while Lanreotide is used for hormonal.
This page compares Abaloparatide and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Abaloparatide | Lanreotide | |
|---|---|---|
| Category | Bone & Joint | Hormonal |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 80 mcg | 60-120 mg |
| Frequency | daily | every 4 weeks |
| Reported benefits | Bone building, osteoporosis treatment, reduced fracture risk | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Similar to teriparatide but milder | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. Abaloparatide is categorised under Bone & Joint, while Lanreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Abaloparatide: FDA-approved. Lanreotide: FDA-approved.
Dosing. Abaloparatide is typically dosed at 80 mcg (daily). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking Abaloparatide and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Abaloparatide and Lanreotide?
- Abaloparatide is primarily a bone & joint peptide, while Lanreotide is used for hormonal. Abaloparatide is FDA-approved for one or more indications, whereas Lanreotide is FDA-approved for one or more indications.
- What is Abaloparatide used for?
- Advanced bone anabolic.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take Abaloparatide and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking Abaloparatide and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Abaloparatide or Lanreotide FDA-approved?
- Abaloparatide is FDA-approved for one or more indications. Lanreotide is FDA-approved for one or more indications.
Read the full articles
- Abaloparatide — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references